Recent progress in the discovery of natural inhibitors against human carboxylesterases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent progress in the discovery of natural inhibitors against human carboxylesterases

Published:2017-03 Issue: Volume:117 Page:84-95
ISSN:0367-326X
Container-title:Fitoterapia
language:en
Short-container-title:Fitoterapia

Author:

Wang Dan-Dan,Zou Li-Wei,Jin Qiang,Hou Jie,Ge Guang-Bo,Yang Ling

Funder

National Basic Research Program of China

NSF

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,General Medicine

Reference113 articles.

1. The mammalian carboxylesterases: from molecules to functions;Satoh;Annu. Rev. Pharmacol. Toxicol.,1998

2. Mammalian carboxylesterases: from drug targets to protein therapeutics;Redinbo;Drug Discov. Today,2005

3. Current progress on esterases: from molecular structure to function;Satoh;Drug Metab. Dispos.,2002

4. Human carboxylesterase isozymes: catalytic properties and rational drug design;Imai;Drug Metab. Pharmacokinet.,2006

5. Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog cynomolgus monkey, and human;Williams;Drug Metab. Dispos.,2011

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrazolone compounds could inhibit CES1 and ameliorates fat accumulation during adipocyte differentiation;Bioorganic Chemistry;2024-09

2. Enzyme-responsive design combined with photodynamic therapy for cancer treatment;Drug Discovery Today;2024-05

3. New bysspectin A derivatives as potent inhibitors of human carboxylesterase 2A;European Journal of Medicinal Chemistry;2023-11

4. Hormetic effects of EGC and EGCG on CES1 activity and its rescue from oxidative stress in rat liver S9;Chemico-Biological Interactions;2023-09

5. Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis;Biochemical Pharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3